New Jersey 2024-2025 Regular Session

New Jersey Senate Bill S1822

Introduced
1/9/24  

Caption

Requires performance of myeloma screening under certain circumstances.

Impact

If enacted, S1822 would supplement Title 26 of the Revised Statutes by specifying the requirements for health screenings. This legislation is positioned as a proactive measure to enhance public health outcomes by addressing the significant gap in early detection of myeloma. It aims to streamline healthcare practices and ensure that all male patients are provided with essential cancer screening during their annual health check-ups, which may contribute to lower mortality rates associated with late-stage diagnoses.

Summary

Senate Bill S1822 aims to make myeloma screenings a standard part of annual physical examinations for male patients. This legislative initiative recognizes the high incidence rates of myeloma, a type of cancer affecting plasma cells, particularly among male patients, with an emphasis on the alarming statistics for African American men who face the highest rates of both incidence and mortality from this disease. The bill seeks to mandate licensed healthcare professionals to include a myeloma screening in their examinations to ensure early detection and treatment options for patients.

Contention

Notably, the legislation does not explicitly outline how these screenings will be implemented or reimbursed within the existing healthcare framework, which could raise concerns among healthcare providers regarding resource allocation and patient management. Additionally, while the focus on myeloma screening is commendable, some voices may argue that more comprehensive policies addressing various health disparities in minority populations are necessary. Thus, the bill may be debated in terms of its sufficiency in addressing broader healthcare equity issues.

Companion Bills

NJ A4786

Carry Over Requires performance of myeloma screening under certain circumstances.

Previously Filed As

NJ A4786

Requires performance of myeloma screening under certain circumstances.

NJ SCR29

Multiple Myeloma Awareness Month.

NJ SB1314

Health insurance; coverage requirements for prostate cancer screenings.

NJ HB2097

Health insurance; coverage requirements for prostate cancer screenings.

NJ A4848

Requires health care professionals to perform lead screening on pregnant persons under certain circumstances.

NJ S2305

Requires health insurers to cover colorectal cancer screenings recommended by United States Preventive Services Task Force and eliminates cost-sharing requirements for certain colonoscopies.

NJ A3523

Requires health insurers to cover colorectal cancer screenings recommended by United States Preventive Services Task Force and eliminates cost-sharing requirements for certain colonoscopies.

NJ S3616

Requires health care professionals to perform lead screening on pregnant persons under certain circumstances.

NJ SR18

Expressing Support For The Designation Of March 2024 As National Multiple Myeloma Awareness Month."

NJ ACR166

Leukemia, Lymphoma, and Myeloma Awareness Month.

Similar Bills

CA AB1315

California American Freedmen Affairs Agency.

CA AB1554

American Indian education.

CA SCR96

Southeast Asian Americans: resettlement.

HI SB138

Relating To Education.

HI SB138

Relating To Education.

HI SB2225

Relating To Education.

CA AB389

Native American repatriation: California Native American Graves Protection and Repatriation Act of 2001: California State University.

CA AB52

Native American resources.